Net Cash Provided by (Used in) Operating Activities |
812M |
USD |
+29.5% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
274M |
USD |
-79.9% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-2.18B |
USD |
-31% |
Q4 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q3 2024 |
FY 2024 |
Common Stock, Shares, Issued |
249M |
shares |
0% |
Q4 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.13B |
USD |
-428% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
158M |
USD |
+3.33% |
Q3 2024 |
FY 2024 |
Operating Lease, Liability |
778M |
USD |
+7.22% |
Q3 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
2.12B |
USD |
+46.5% |
Q4 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
3.37B |
USD |
+38.4% |
Q4 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid |
1.08B |
USD |
+8.77% |
Q3 2024 |
FY 2024 |
Property, Plant and Equipment, Gross |
41.1B |
USD |
+18.1% |
Q4 2024 |
Q1 2025 |
Operating Lease, Liability, Current |
100M |
USD |
+5.91% |
Q3 2024 |
FY 2024 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.03 |
pure |
0% |
Q3 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
-6.3M |
USD |
-147% |
Q4 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
301M |
USD |
+13% |
Q3 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
132M |
USD |
-6.77% |
Q3 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q3 2024 |
FY 2024 |
Unrecognized Tax Benefits |
101M |
USD |
+4.66% |
Q3 2024 |
FY 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
367M |
USD |
+5.04% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
322M |
USD |
+25.7% |
Q3 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
64.6M |
USD |
+12.5% |
Q4 2024 |
Q1 2025 |
Interest Expense |
209M |
USD |
+41.8% |
Q1 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2024 |
FY 2024 |